Biomea Fusion Statistics

Total Valuation

Biomea Fusion has a market cap or net worth of $86.23 million. The enterprise value is $27.89 million.

Market Cap	86.23M
Enterprise Value	27.89M

Important Dates

The next estimated earnings date is Monday, May 5, 2025, after market close.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Biomea Fusion has 37.57 million shares outstanding. The number of shares has increased by 5.86% in one year.

Current Share Class	37.57M
Shares Outstanding	37.57M
Shares Change (YoY)	+5.86%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	12.25%
Owned by Institutions (%)	54.01%
Float	29.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.45
P/TBV Ratio	1.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.15, with a Debt / Equity ratio of 0.17.

Current Ratio	3.15
Quick Ratio	2.69
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -125.38% and return on invested capital (ROIC) is -75.07%.

Return on Equity (ROE)	-125.38%
Return on Assets (ROA)	-64.35%
Return on Invested Capital (ROIC)	-75.07%
Return on Capital Employed (ROCE)	-247.27%
Revenue Per Employee	n/a
Profits Per Employee	-$1.31M
Employee Count	106
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.10% in the last 52 weeks. The beta is -0.09, so Biomea Fusion's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-79.10%
50-Day Moving Average	2.53
200-Day Moving Average	5.70
Relative Strength Index (RSI)	54.65
Average Volume (20 Days)	804,104

Short Selling Information

The latest short interest is 10.47 million, so 27.85% of the outstanding shares have been sold short.

Short Interest	10.47M
Short Previous Month	10.38M
Short % of Shares Out	27.85%
Short % of Float	35.60%
Short Ratio (days to cover)	15.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-144.07M
Pretax Income	-139.65M
Net Income	-138.43M
EBITDA	-142.32M
EBIT	-144.07M
Earnings Per Share (EPS)	-$3.83

Full Income Statement

Balance Sheet

The company has $58.28 million in cash and $8.77 million in debt, giving a net cash position of $49.51 million or $1.32 per share.

Cash & Cash Equivalents	58.28M
Total Debt	8.77M
Net Cash	49.51M
Net Cash Per Share	$1.32
Equity (Book Value)	51.57M
Book Value Per Share	1.42
Working Capital	46.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$119.89 million and capital expenditures -$362,000, giving a free cash flow of -$120.26 million.

Operating Cash Flow	-119.89M
Capital Expenditures	-362,000
Free Cash Flow	-120.26M
FCF Per Share	-$3.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biomea Fusion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.86%
Shareholder Yield	-5.86%
Earnings Yield	-178.85%
FCF Yield	-155.37%

Analyst Forecast

The average price target for Biomea Fusion is $28.45, which is 1,139.65% higher than the current price. The consensus rating is "Buy".

Price Target	$28.45
Price Target Difference	1,139.65%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-8.77%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1